4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-22-004784
Options or other derivatives
- Head of Pharm Ops and Tech acquired 6,815 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murphy Nicole Head of Pharm Ops and Tech | 2022-02-10 | Grant or award · Restricted Stock Unit | +6,815 | 6,815 | D: show line 1 in the form |
Loading xslF345X03/form4.xml…